Automated description from the Alliance of Genome Resources (Release 3.2)
Predicted to have prostaglandin F receptor activity. Involved in several processes, including negative regulation of apoptotic process; response to estradiol; and response to lipopolysaccharide. Predicted to localize to cytoplasm and plasma membrane. Is expressed in cloaca; genital tubercle; jaw; and viscerocranium. Orthologous to human PTGFR (prostaglandin F receptor).